English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Mitral regurgitation (MR) is a common valvular disorder that can result in congestive heart failure and cardiovascular death. Patient suffering from this condition are frequently not referred and thus the condition is under-treated. Surgery remains the gold standard treatment for mitral valve disease, however, catheter based mitral valve interventions, including repair and replacement, are being employed to treat patients who are deemed high or prohibitive risk for conventional surgery. TIARA is one of the many newly developed transcatheter mitral valve replacement (TMVR) systems that may address this unmet need.

Early experience of TIARA transcatheter mitral valve replacement system